Wybierz wielkość
| Rozmiar/SKU | Dostępność | Cena netto |
|---|---|---|
5 mg | Dostępne do wysyłki DZISIAJzKuehne + Nagel Sp. z o.o. | 516,00 zł |
25 mg | Przewidywany termin wysyłki14 września 2026zKuehne + Nagel Sp. z o.o. | 2180,00 zł |
100 mg | Przewidywany termin wysyłki14 września 2026zKuehne + Nagel Sp. z o.o. | 8790,00 zł |
Informacje o tej pozycji
Nazwa produktu
Paclitaxel, Taxus sp., Antitumor and antileukemic agent isolated from the bark of the yew tree.
Quality Segment
description
Merck USA index - 14, 6982
assay
≥98% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, desiccated, protect from light
color
white
solubility
methanol: 1 mg/mL, DMSO: 10 mg/mL
shipped in
ambient
storage temp.
−20°C
SMILES string
N([C@H]([C@@H](O)C(=O)O[C@H]3C[C@]4([C@H](C6[C@]7([C@H](OC7)C[C@@H]([C@]6(C(=O)[C@@H](C(=C3C)C4(C)C)OC(=O)C)C)O)OC(=O)C)OC(=O)c5ccccc5)O)c2ccccc2)C(=O)c1ccccc1
InChI
1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38?,40-,45+,46-,47+/m0/s1
InChI key
RCINICONZNJXQF-VAZQATRQSA-N
General description
Biochem/physiol Actions
Promotes assembly of microtubules and inhibits tubulins disassembly
Preparation Note
Other Notes
Milas, L., et al. 1995. Cancer Chemother. Pharmacol.35, 297.
Donaldson, K.L., et al. 1994. Int. J. Cancer 57, 847.
Hornback, N.B., et al. 1994. In Vivo8, 819.
Manthey, C.L., et al. 1992. J. Immunol. 149, 2459.
Rowinsky, E.K., et al. 1992. Semin. Oncol.19, 646.
Ding, A.H., et al. 1990. Science248, 370.
Mogensen, M.M. and Tucker, J.B. 1990. J. Cell Sci.97, 101.
Slichenmeyer, W.J. and Von Hoff, D.D. 1990. J. Clin. Pharmacol. 30, 770.
Legal Information
Disclaimer
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description Antitumor and antileukemic agent isolated from the bark of the yew tree. | description A semi-synthetic form of Paclitaxel having no contamination by natural taxanes. Also has reduced levels of epimerization products as contaminants. | description European Pharmacopoeia (EP) Reference Standard | description from Taxus yannanensis, powder |
| assay ≥98% (HPLC) | assay ≥97% (HPLC) | assay - | assay - |
| form solid | form crystalline solid | form - | form powder |
| Quality Level 100 | Quality Level 100 | Quality Level - | Quality Level 200 |
| manufacturer/tradename Calbiochem® | manufacturer/tradename Calbiochem® | manufacturer/tradename EDQM | manufacturer/tradename - |
| storage temp. −20°C | storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C |
| storage condition protect from light, OK to freeze, desiccated | storage condition protect from light, desiccated, OK to freeze | storage condition - | storage condition - |
Still not finding the right product?
Explore all of our products under Paclitaxel, Taxus sp.
signalword
Danger
hcodes
Hazard Classifications
Muta. 2 - Repr. 1B - STOT RE 1
target_organs
Central nervous system,Bone marrow,Cardio-vascular system
Klasa składowania
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
flash_point_f
Not applicable
flash_point_c
Not applicable
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.


